Edition:
India

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

608.55INR
17 Nov 2017
Change (% chg)

Rs15.70 (+2.65%)
Prev Close
Rs592.85
Open
Rs607.00
Day's High
Rs614.90
Day's Low
Rs600.65
Volume
1,448,847
Avg. Vol
1,407,255
52-wk High
Rs663.40
52-wk Low
Rs480.20

Latest Key Developments (Source: Significant Developments)

Cipla gets final approval for generic Pulmicort Respules
Friday, 17 Nov 2017 

Nov 17 (Reuters) - Cipla Ltd ::Cipla receives final approval for generic Pulmicort Respules.Drug indicated for maintenance treatment of asthma, as prophylactic therapy in children 12 months to 8 years of age.Product available for shipping immediately.  Full Article

India's Cipla Sept qtr consol profit up about 19 pct
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Cipla Ltd :Sept quarter consol net profit 4.23 billion rupees versus profit of 3.54 billion rupees last year.Consensus forecast for sept quarter consol net profit was 4.20 billion rupees.Sept quarter consol net sales 39.88 billion rupees versus 36.72 billion rupees last year.  Full Article

Cipla says US unit gets USFDA final approval for generic Renvela tablets‍​
Friday, 27 Oct 2017 

Oct 27 (Reuters) - Cipla Ltd :Says us subsidiary receives final approval for generic Renvela tablets‍​.  Full Article

Cipla's U.S. unit gets final FDA nod for generic Renvela tablets
Friday, 27 Oct 2017 

Oct 27 (Reuters) - Cipla Ltd ::Says co's U.S. unit gets final FDA nod for generic Renvela tablets ‍​.  Full Article

India's Cipla March-qtr loss narrows
Thursday, 25 May 2017 

May 25 (Reuters) - Cipla Ltd :Consol March quarter net loss 617.9 million rupees.Consol march quarter total income from operations 35.82 billion rupees.Recommended payment of dividend of 2 rupees per share.Consol net loss in March quarter last year was 928.3 million rupees as per Ind-AS; consol total income from operations was 33.15 billion rupees.  Full Article

Cipla gets EIR from USFDA for its Indore facility
Wednesday, 12 Oct 2016 

Cipla Ltd :Cipla receives EIR from the US FDA for its Indore facility.  Full Article

Cipla Ltd exec says co expects about 200 mln rupees of impact from FDC ban, NLEM in Q2
Friday, 12 Aug 2016 

Cipla Ltd : Cipla's Samina Vaziralli says "the family is completely committed", "absolutely no prospect" of selling the company . Exec says expects about 200 million rupees of impact from FDC ban and NLEM in Q2 . Further company coverage [CIPL.NS] ((Bangalore.newsroom@thomsonreuters.com)).  Full Article

Cipla Ltd appoints Umang Vohra as MD, global CEO
Friday, 12 Aug 2016 

Cipla Ltd : Accepted resignation of Subhanu Saxena as MD and global CEO wef August 31 . Appointed Umang Vohra as MD and global CEO .  Full Article

Cipla Ltd June-qtr consol profit down about 44 pct
Friday, 12 Aug 2016 

Cipla Ltd : June-quarter consol net profit 3.65 billion rupees . June-quarter consol net sales 35 billion rupees . Consensus forecast for June-quarter net profit was 3.76 billion rupees . Consol net profit in June-quarter last year was 6.49 billion rupees as per Ind-AS; consol net sales was 37.61 billion rupees .  Full Article

Cipla appoints Kedar Upadhye as CFO
Monday, 1 Aug 2016 

Cipla Ltd : Kedar Upadhye has joined the company as Global Chief Financial Officer with effect from August 01, 2016 . Umang Vohra relinquishes office as Global Chief Financial Officer of the company with effect from August 01, 2016 .  Full Article

Photo

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.